Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Charissa Borja-Tabora, Delia Yu, Pope Kosalaraksa, Felix Espinoza, Eduardo López-Medina, Lulu Bravo, Luis Rivera, Shibadas Biswal, Xavier Sáez-Llorens, Humberto Reynales, Chukiat Sirivichayakul, Luis Martinez Vargas, Veerachai Watanaveeradej, Reynaldo Dietze, LakKumar Fernando, Pujitha Wickramasinghe, Edson Duarte MoreiraJr, Asvini D Fernando, Dulanie Gunasekera, Kleber Luz, Rivaldo Venâncioda Cunha, Martina Rauscher, Olaf Zent, Mengya Liu, Elaine Hoffman, Inge LeFevre, Vianney Tricou, Derek Wallace, MariaTheresa Alera, Astrid Borkowski
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022;75(1):107-117